Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | -28.57% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 17-04-30 |
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 14-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 97-11-10 |
Peter Marks
BRD | Director/Board Member | 68 | 05-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 11-08-07 |
Brian Meltzer
BRD | Director/Board Member | 70 | 99-12-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,802,360,380 | 2,436,015,074 ( 86.93 %) | 0 | 86.93 % |
Company contact information
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.57% | 20.69M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- ATH Stock
- Company Alterity Therapeutics Limited